Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22766773 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: bevacizumab;   Drug: enzastaurin hydrochloride;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study

Indicates status has not been verified in more than two years